Actuate Therapeutics, Inc. announced that their Phase 2 open-label single arm study of elraglusib (9-ING-41) plus gemcitabine/nab-paclitaxel treatment met...
Read moreSivers Semiconductors AB has entered into an agreement to acquire 100 per cent of the share capital of MixComm...
Read moreFoldax® announced completion of enrollment in the U.S. early feasibility study of the TRIA™ surgical aortic heart valve. The...
Read moreReal 5G needs millimeter wave radio, and the iPhone 13 alone isn't going to make that happen. It's time...
Read moreMemVerge® announced Memory Machine™ Big Memory virtualization software has been selected by Penn State Huck Institutes of the Life...
Read moreClearsense announced the acquisition of Compellon, a privately-held, plug-and-play AI analytics company based in Lake Forest, California.
Read moreElectric vehicles (EVs) will play a huge role in creating a greener transportation ecosystem in the years ahead as...
Read moreJim Demetriades is the Founder and CEO of venture capital investment company, Kairos Ventures, real estate development and...
Read moreGuRu's wireless power tiles were on display Wednesday at Tech World 2021, an event run by Motorola parent company...
Read moreMixComm announced that its RFSOI beamforming technology was recognized among the best by the 2021 Military & Aerospace Electronics...
Read more